VitaPCR™ Assays Enable Detection of the latest SARS-CoV-2 Variant Strain
Singapore, February 9, 2023 – Detection of the latest S […]
Singapore, February 9, 2023 – Detection of the latest S […]
Focusing on research and development of revolutionary diagnostic technologies since 2011, Credo Diagnostics develops, manufactures, and commercializes accurate, rapid, and affordable molecular diagnostic solutions at the Point-Of-Care testing.
© 2023 | Credo Diagnostics Biomedical Pte. Ltd.